Paul C. Raymond - 04 Dec 2025 Form 4 Insider Report for Calumet, Inc. /DE (CLMT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Dec 2025, 15:55:54 UTC
Prior SEC filing
10 Nov 2025
Next SEC filing
26 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Connor J. Egan, as attorney-in-fact

Key filing fact

Paul C. Raymond filed Form 4 for Calumet, Inc. /DE (CLMT) on 05 Dec 2025.

Key facts

  • This page summarizes Paul C. Raymond's Form 4 filing for Calumet, Inc. /DE (CLMT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 05 Dec 2025, 15:55.

Change

  • Previous filing in this sequence was filed on 10 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001316627 Primary reporting owner

Raymond Paul C

Relationship
Director
Address
1060 N CAPITOL AVE, SUITE 6-401, INDIANAPOLIS
Signature
/s/ Connor J. Egan, as attorney-in-fact
Signature date
05 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLMT transaction

Common Stock, par value $0.01 per share

Options Exercise

Transaction value
$0
Shares
+5,053
Change %
+26%
Price
$0.000000
Shares after
24,733
Date
04 Dec 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLMT transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-5,053
Change %
-100%
Price
$0.000000
Shares after
0
Date
04 Dec 2025
Ownership
Direct
Underlying class
Common Stock, par value $0.01 per share
Underlying amount
5,053
Exercise price
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.

Footnote F2

Each Restricted Stock Unit becomes payable either in the form of one share of Calumet, Inc. common stock, par value $0.01 per share, or the cash value thereof. Restricted Stock Units are 100% vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .